Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
NHL
Social Media
World Cup
Formula 1
Music
Natural Disasters
Work
Donald Trump
Amazon
NBA
Artificial Intelligence
Immigration
Published • loading... • Updated

No Survival, Recurrence Benefit With Aspirin in CRC Liver Metastases

Summary by oncnursingnews.com
Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at the 2025 ASCO Meeting.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
oncnursingnews.comoncnursingnews.com

No Survival, Recurrence Benefit With Aspirin in CRC Liver Metastases

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at the 2025 ASCO Meeting.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

oncnursingnews.com broke the news in on Wednesday, June 25, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Chicago, IL icon

Chicago, IL

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal